Neuramis Light with Lidocaine: Ultra-Fine HA Filler with Anesthetic for Subtle Line Correction & Hydration
Neuramis Light with Lidocaine, manufactured by **LG Chem Life Sciences**, is the **finest and least viscous** dermal filler within the Neuramis range, featuring **integrated 0.3% lidocaine** for enhanced patient comfort. Presented in a **1.0 ml prefilled syringe**, it contains a **lower concentration (15 mg/ml) of cross-linked hyaluronic acid (HA)** compared to other Neuramis products. Its ultra-smooth, low-viscosity formulation is specifically engineered for the **superficial correction of very fine lines and wrinkles**, as well as improving overall skin hydration and radiance in delicate areas. The integrated lidocaine minimizes injection discomfort.https://skin-reboot.com/
**Core Technology & Properties:**
* **Premixed Monophasic NASHA Gel:** Features a homogeneous, low-density, non-animal stabilized HA matrix cross-linked with BDDE for biocompatibility and natural integration.
* **Integrated 0.3% Lidocaine HCl:** Provides rapid local anesthesia during injection, improving tolerance, especially in sensitive superficial zones.
* **Low G-Prime (Elasticity):** Exhibits **high flexibility and low resistance to deformation**, allowing it to flow easily and integrate seamlessly into the upper dermis for subtle smoothing without creating volume or lift.
* **Low Viscosity & Cohesivity:** Designed for easy distribution through fine needles and gentle spreading within tissue, minimizing lumpiness and ensuring a smooth result. Less cohesive than deeper fillers.
* **Optimized for Superficial Placement:** Fine particle size and fluid consistency prevent visibility (Tyndall effect) when correctly injected intradermally.
**Mechanism of Action:**
1. **Line Filling & Smoothing:** Low-G’ gel integrates superficially to physically fill fine creases and wrinkles upon injection.
2. **Hydration & Radiance:** HA binds significant water molecules, deeply hydrating the skin from within, improving texture, luminosity, and reducing the appearance of dehydration lines.
3. **Biostimulation:** Gently stimulates collagen production over time for subtle, sustained skin quality improvement.
4. **Anesthesia:** Lidocaine blocks local pain signals for a more comfortable injection experience.
**Primary Indications:**
* **Very Fine Lines & Wrinkles:** Superficial crow’s feet, periorbital lines, forehead lines (fine), glabellar lines (mild).
* **Perioral Rhytids (Smoker’s Lines):** Correction of fine vertical lip lines.
* **Cheekbone & Décolleté Fine Lines:** Delicate superficial wrinkles in these areas.
* **Overall Skin Hydration & Quality:** Improving radiance, smoothness, and reducing the look of superficial dehydration lines via mesotherapy-like techniques (“skin boosting”).
* **Refinement & Finishing Touch:** Often used alongside deeper fillers for comprehensive rejuvenation.
**Key Administration Considerations:**
* **Ready-to-Use:** No reconstitution required. Prime syringe carefully.
* **Anesthesia:** Integrated lidocaine provides core comfort; adjunctive topical numbing cream is highly recommended for sensitive areas like lips/eyes.
* **Technique:** Primarily suited for **linear threading or serial puncture**:
* **Needles:** Sharp, ultra-fine needles (e.g., **30-33G**, 0.5″ or 13mm) are essential for precise **intradermal or superficial subdermal** injection. *Avoid deep placement.*
* **Cannulas:** Less commonly used than with deeper products; if used, very fine cannulas (e.g., 27G+) for superficial planes.
* **Depth:** **Papillary or upper reticular dermis.** *Critical to stay superficial.*
* **Volume:** Small amounts per injection point (tiny boluses or threads). Subtle, gradual correction is key. Overcorrection easily visible.
* **Post-Treatment:** Mild redness, pinpoint bleeding, swelling, and potential bruising are common but typically resolve quickly. Avoid pressure/massage.
* **Longevity:** Results typically last **6-9 months**, reflecting its lower HA concentration and superficial placement where metabolic activity is higher.
* **Safety:** Standard filler risks. **Critical Risks:** **Tyndall effect** (bluish discoloration) if injected *too superficially* (intradermal is safe, avoid sub-epidermal). Vascular occlusion risk is lower than with deep fillers but still requires anatomical knowledge and aspiration. Risk of visible nodules/beading if overfilled or technique too bolus-like. Lidocaine allergy screening essential.
* **Regulatory Status:** **CE marked** (Europe/international). **Not FDA-approved in the USA.**
* **Prescription:** Prescription medical device.
Neuramis Light with Lidocaine offers a comfortable, precise solution for achieving subtle, natural-looking correction of fine lines and enhancing skin hydration, leveraging a low-G’ monophasic HA gel with integrated anesthetic designed for superficial artistry.CONTACT US

Reviews
There are no reviews yet.